medigraphic.com
ISSN 1996-3521 (Electronic)

2022, Number 37

<< Back Next >>

INFODIR 2022; 18 (37)

Economic overview of health care for asthma patients

Collazo HM, Venero FSJ, Chaviano PI

Language: Spanish
References: 44
Page: 1-19
PDF size: 417.14 Kb.


ABSTRACT

Introduction: Asthma is one of the most costly diseases for the national health system, due to the substantial resources required for its treatment and prevention.
Objective: To describe the costs of asthma, both direct and indirect, nationally and internationally.
Development: A bibliographic review was carried out at national and international level, in order to know the magnitude of the economic resources required for the control of this disease. The national and international data presented, both in economic terms and in epidemiological aspects, clearly indicated that asthma has a considerable socioeconomic effect on public health in different countries, since most of the total cost of asthma is derived from poor control of the disease, expressed both in indirect costs, as well as an important part of the direct costs that comprised expenses for hospitalization, visits to medical emergencies, etc.
Conclusions: It is essential to have the necessary knowledge about the economic aspects of asthma, because of the importance of the costs of medicale care for health institutions, the implications of the expenses for the patient himself and the families, as well as the indirect costs due to the loss of labor productivity of people afflicted with this disease.


REFERENCES

  1. Global Burden of Disease Study 2015. Disease and injury incidence and prevalence collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388:1545–602.

  2. World Health Organization. The global asthma report 2018. Global Asma Network. Geneva: WHO. 2019 [acceso 25/11/2019]. Disponible en: http://www.globalasthmareport.org/

  3. Organización Mundial de la Salud. Asma. Ginebra: OMS. 2012 [acceso 23/10/2019]. Disponible en: https://www.who.int/news-room/fact-sheets/detail/asthma.

  4. Sher I, Pearce N. Global burden of asthma among children. Int J Tuber clung Dis. 2014;18:1269-78.

  5. 5.Weiss KB, Sullivan SD, Lyttle CS. Trends in the cost of ill-ness for asthma in the United States, 1985-1994.J Allergy ClinImmunol. 2000;106:493-9.

  6. Muñoz F. Asma: endotipos y fenotipos en la edad pediátrica. Rev. Alerg. Méx. 2019 [acceso 23/01/2020];66(3):[aprox. 5p.]. Disponible en: Disponible en: http://www.scielo.org.mx/scielo.php

  7. Stolle RM. Actualización de los principales problemas de salud. Asma Bronquial. Barcelona: Sociedad Española de Medicina de Familia y Comunitaria. 2015 [acceso 28/11/2019]. Disponible en: Disponible en: https://amf-semfyc.com/upload_revisions/26_Actualizacion_Web_Febrero2015.pdf

  8. Rutman L, Migita R, Spencer S, Kaplan R, Klein EJ. Standardized asthma admission criteria reduce length of stay in a pediatric emergency department. Acad. Emerg. Med. 2016;23(3):289-9610.

  9. Anceaume ME. Estudio sobre asma bronquial en la edad pediátrica en el área de salud del Policlínico-Hospital Luis de la Puente Uceda durante el año 2007. La Habana: Universidad de Ciencias Médicas de La Habana. 2007 [acceso 23/09/2019]. Disponible en: http://www.cursosparamedicos.com/newsite/pags/ac_cient/monos/asma_infancia.pdf

  10. Álvarez M, Docando N, Álvarez A, Dotres C, Baños D, Sardiñas ME, et al. Comportamiento del asma bronquial en un área de salud del policlínico Cerro. Rev. Cubana. Med. Gen. Integr. 2011 [acceso 03/08/2018];27(1):[aprox. 12 p.]. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-21252011000100006&lng=es

  11. Solís SK, Bañuelos OC, Anderson LL. Caracterización clínica y terapéutica de pacientes pediátricos con crisis asmáticas. Med. Asoc. Med. Hosp. 2013 [acceso 29/04/2017];58(3):[aprox. 5p.]. Disponible en: https://www.medigraphic.com/cgibin/new/resumenI.cgi

  12. British Thoracic Society. British guideline on the management of asthma. London: British Thoracic Society. 2016 [acceso 12/01/2019]. Disponible en: https://www.brit-thoracic.org.uk

  13. Castro JA, Beckhaus AA, Forno E. Efficacy of oral corticosteroids in the treatment of acute wheezing episodes in asthmatic preschoolers: systematic review with meta-analysis. PediatrPulmonol. 2016;51(8):868-76.

  14. Ebisawa M, Ito K, Fujisawa T. Japanese guidelines for food allergy 217. AllergolInt. 2017;66(2):248-64.

  15. Moral VP. Guía española para el manejo del asma. Arch Bronconeumol. 2015 [acceso 18/06/2019];51(Suppl. 1):[aprox. 50 p.]. Disponible en: https://www.sciencedirect.com/science/article/abs/pii/S030028961532812X

  16. Asensi M. Crisis de asma. Rev. Pediatr Aten Primaria. 2017 [acceso 26/06/2019];19(Suppl 26):17-25. Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1139-76322017000300002&lng=es

  17. Quintana J, Méndez VM, Méndez Y, Álvarez J, Quinto B. Intervención educativa sobre asma bronquial en padres de niños con esta enfermedad en Anzoátegui, Venezuela. Rev. Inf. Cient. 2018 [acceso 17/06/2019];97(1):[aprox. 9 p.]. Disponible en: http://www.revinfcientifica.sld.cu/index.php/ric/article/view/1825

  18. 18.Jin E, Simonson J, Jaxome S, Conigliario J, Amresh D. Disparities in complementary alternative medicine use and asthma in the United States. J Asthma. 2019. DOI: http://dx.doi.org/10.1080/02770903.2019.1614615

  19. Portilla H, González K, González V, González JM. Terapia natural para el tratamiento del asma bronquial. Rev. Cie. Médicas. 2012 [acceso 17/06/2019];12(2):[aprox. 10 p.]. Disponible en: http://www.medigraphic.com/pdfs/revciemedhab/cmh-2012/cmh122e.pdf

  20. Wu W, Bang S, Bleecker ER, Castro M, Denlinger L, Erzurum SC, et al. Multiview Cluster Analysis Identifies Variable Corticosteroid Response Phenotypes in Severe Asthma. Am J Respir Crit Care Med. 2019;199(11):[aprox. 10p.]. DOI: https://doi.org/10.1164/rccm.201808-1543OC

  21. Bonser LR, Erle DJ. The airway epithelium in asthma. En: Advances in Immunology. 1st ed. Vol. 142. Elsevier Inc.; 2019. p. 1-34. DOI: http://dx.doi.org/10.1016/bs.ai.2019.05.001

  22. Rodríguez JAC, Krause B, Uauya R, Casanello P. Epigenética en enfermedades alérgicas y asma. Rev Chil Ped. 2016 [acceso 17/06/2019];41(6). Disponible en: http://revzoilomarinello.sld.cu/index.php/zmv/article/view/714

  23. GINA. Global Strategy for Asthma Management and Prevention. Geneva: Global Iniciative for Asma. 2019 [acceso 20/05/2020]. Disponible en: https://ginasthma.org/reports/2019-gina-report-global-strategy-for-asthma-management-and-prevention/

  24. Lambrecht BN, Hammad H, Fahy JV. 25 Review The cytokines of asthma. Immunity. 2019;50(4):[aprox. 15p.]. DOI: https://doi.org/10.1016/j.immuni.2019.03.018

  25. Gordon ED, Simpson LJ, Rios CL, Ringel L, Lachowicz- ME, Peters MC, et al. Alternative splicing of interleukin-33 and type 2 inflammation in asthma. Research Gate. 2016 [acceso 20/05/2020];113(31):[aprox. 15 p.]. Disponible en: https://www.researchgate.net/publication/305419006

  26. Venero S, Suarez R, Mora-Faife E, Garcia G, Valle I, Gomez L, et al. Factors for wheeze in infants in Cuba. Risk Quarterly J Med. 2013;106:1023-9.

  27. González AT, Cabrera MC, González A, González L, Triana Y. Comportamiento de la sibilancia en niños menores de cinco años de la provincia Sancti Spíritus. Rev. Inform. Cient. 2018 [acceso 12/06/2019];97(3):[aprox. 8 p.]. Disponible en: http://scielo.sld.cu/pdf/ric/v97n3/1028-9933-ric-97-03-538.pdf

  28. Hernández SH, Rodríguez MA, Machín MT, García A, Prat Ribet I. Tratamiento del asma bronquial en niños según la medicina Bioenergética y Natural. Rev. Cien. Médicas. 2015 [acceso 17/06/2019];19(2): [aprox. 9 p.]. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-21251999000400013

  29. Xu D, Wang Y, Chen Z, Li S, Cheng Y, Zhang L, et al. Prevalence and risk factors for asthma among children aged 0-14 years in Hangzhou: a cross-sectional survey. Respir Res. 2016;17(1):122.

  30. Godard P, Chanez P, Siraudin L, Nicoloyannis N, Duru G. Costs of asthma are correlated with severity: a 1-yr prospective study. Eur Respir. 2001;19:61-7.

  31. Leigh JP, Romano PS, Schenker MB, Kreiss K. Costs of occupational COPD and Asthma.Chest. 2002;121:264-72.

  32. Salgado G, Ceballos Z, Sandoval L, Hernández V. Agudizaciones del asma y sus costos de atención en el servicio de urgencias. Revista Alergia México 2006;53(2):64-8.

  33. Vandenplas O, Toren K, Blanc PD. Health and socioeconomic impact of work-related asthma. European Respiratory Journal. 2003;22:689-97.

  34. 34.Birnbaum HG, Berger WE, Greenberg PE, Holland M, Auerbach R, Atkins KM, et al. Direct and indirect costs of asthma to an employer. Journal of Allergy and Clinical Immunology. 2002;109:264-70.

  35. VanGanse E, Laforest L, Pietri G, Boissel JP, Gormand F, Ben-Joseph R, et al. Persistent asthma: disease control, resource utilization and direct costs. European Respiratory Journal. 2002;20:260-7.

  36. Schwenkglenks M, Lowy A, Anderhub H, Szucs TD. Costs of asthma in a cohort of Swiss adults: associations with exacerbation status and severity. Value in Health. 2003;6:75-83.

  37. Bootman JL, Crown WH, Luskin AT. Clinical and economic effects of suboptimally controlled asthma. Managed Care Interface. 2004;17:31-6.

  38. Gendo K, Sullivan SD, Lozano P, Finkelstein JA, Fuhlbrigge A, Weiss KB, et al. Resource costs for asthma-related care among pediatric patients in managed care. Annals of Allergy Asthma and Immunology. 2003;91:251-7.

  39. Lodha R, Puranik M, Kattal N, Kabra SK. Social and economic impact of childhood asthma. Indian Pediatrics. 2003;40:874-9.

  40. Feenstra TL, Rutten-Van Molken MP, Jager JC, Van Essen-Zandvliet LE. Cost effectiveness of guideline advice for children with asthma: a literature review. Pediatric Pulmonology. 2002;34:442-54.

  41. 41.Sullivan SD, Weiss KB, Lynn H, Mitchell H, Kattan M, Gergen PJ, et al. The cost-effectiveness of an inner-city asthma intervention for children. Journal of Allergy and Clinical Immunology. 2002;110:576-81.

  42. Kamps AW, Roorda RJ, Kimpen JL, Overgoor-van de Groes AW, van Helsdingen-Peek LC, Brand PL, et al. Impact of nurse-led outpatient management of children with asthma on healthcare resource utilization and costs. European Respiratory Journal. 2004;23:304-9.

  43. Collazo M, Venero S, Suárez R, Sosa I. Estimación de los costos directos institucionales para la atención de los pacientes asmáticos. Cuba 2008-2011 Pharmacoeconomics Spanish Research Articles. 2016. DOI: 10.1007/s40277-016-0057-7

  44. Varona P, García R, Díaz-Pereda G, Gálvez AM. Uso de los servicios de salud y gastos de bolsillo por asma en niños de 5 a 14 años de edad. Ciudad de La Habana, 2002. Rev. Cub. Hig. Epidemiol. 2005 [acceso 17/06/2019];43(3). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_issuetoc&pid=1561300320050003&lng=es&nrm=iso




2020     |     www.medigraphic.com